Tag: Juniper Pharmaceuticals

Industry Focus Areas, Medical

Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results

August 9, 2018

Via: PR Newswire

BOSTON, Aug. 9, 2018 /PRNewswire/ — Juniper Pharmaceuticals, Inc. (Nasdaq:JNP), a diversified healthcare company with core businesses of its CRINONE® (progesterone gel) franchise and fee-for-service pharmaceutical development and manufacturing business, Juniper Pharma Services (“JPS”), today announced financial results for the […]